Filing Flows › 8-K events › Zeo ScientifiX
Zeo ScientifiX: entry into a material definitive agreement
Form 8-K filed Oct 30, 2026 · items 1.01, 3.02
What the filing says
On October 26, 2026, ZEO and Pluri Inc. (Nasdaq and TASE: PLUR) (“ Pluri ”), a Haifa, Israel-based biotechnology company that is engaged in leveraging its proprietary 3D cell expansion platform (the “ Platform ”), entered into a definitive strategic agreement (the “ Partnership Agreement ”) to expand the parties’ U.S.
Read the filing on SEC EDGAR →
What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 3.02: +0.1% next session across 2,750. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
Zeo ScientifiX’s other material 8-Ks
- Nov 3, 2026 — Other events ZEO ScientifiX Makes Industry History as First Facility to Achieve AABB’s Newly Established Quality
- Oct 26, 2026 — Entry into a material definitive agreement Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerati
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.